JAMA Network
About The Study: The results of this study of 1.65 million doses of BNT162b2 (Comirnaty [Pfizer-BioNTech]) vaccinations among adolescents in Ontario, Canada, suggest that there was variation in the reported incidence of myocarditis or pericarditis. However, the risk of these events after vaccination remains very rare and should be considered in relation to the benefits of COVID-19 vaccination.
Authors: Sarah E. Wilson, M.D., M.Sc., of Public Health Ontario in Toronto, is the corresponding author.
To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/
(doi:10.1001/jamapediatrics.2022.6166)
/Public Release. This material from the originating organization/author(s) might be of the point-in-time nature, and edited for clarity, style and length. Mirage.News does not take institutional positions or sides, and all views, positions, and conclusions expressed herein are solely those of the author(s).View in full here.
